Haemonetics (NYSE:HAE) just reported results for the fourth quarter of 2024.
- Haemonetics reported earnings per share of 90 cents. This was above the analyst estimate for EPS of 89 cents.
- The company reported revenue of $343.29 million.
- This was 4.31% better than the analyst estimate for revenue of $329.11 million.